Edition:
United States

BiondVax Pharmaceuticals Ltd (BVXV.OQ)

BVXV.OQ on NASDAQ Stock Exchange Capital Market

6.26USD
23 Feb 2018
Change (% chg)

$0.10 (+1.62%)
Prev Close
$6.16
Open
$6.18
Day's High
$6.26
Day's Low
$6.18
Volume
824
Avg. Vol
4,138
52-wk High
$10.75
52-wk Low
$4.61

Chart for

About

BiondVax Pharmaceuticals Ltd is an Israel-based biopharmaceutical company. The Company holds a worldwide exclusive license granted by Yeda Research and Development Ltd., the commercial arm of the Weizmann Institute, Israel, for developing, manufacturing and commercializing the flu vaccine. BiondVax Pharmaceuticals Ltd develops a... (more)

Overall

No Ratios Available.

Financials

  Industry Sector
P/E (TTM): -- 195.87 16.59
EPS (TTM): -- -- --
ROI: -- -0.71 35.07
ROE: -- -3.37 17.79

Earnings vs. Estimates